Ying Huang, Ph.D., steps down as Chief Executive Officer and member of the Board of Directors; will remain as an advisor ...

Move over, Silicon Valley. Biotech entrepreneur Michael Triplett is quietly positioning Ohio to become the world’s next ...

Most biotech investors treat FBT and IBB as two names for the same trade, but the structural differences buried in their ...

By Deena Beasley July 22 (Reuters) - Biotech experts and industry executives are calling plans by the U.S. Food and Drug ...

VXA-222 advances into next phase at VERAXAZURICH, SWITZERLAND, July 27, 2026 -- VERAXA Biotech AG (NASDAQ: VRXA; “VERAXA” or the "Company"), an emerging leader in designing novel cancer therapies, ...

Once attention exists, you have the opportunity to explain the mission, communicate the science clearly, build trust and ...

Discover the best biotech ETFs to diversify your portfolio, gain exposure to cutting-edge biotech innovations, and reduce risk in a volatile sector.

Netherlands- and Belgium-based biotech argenx has agreed to buy US biotech Forte Biosciences for up to $2.2 billion, ...

A recovering IPO market, surging mergers and acquisitions fuel more biotech venture deals.

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more ...

A former doctor accused of sexual assault but on the run for 20 years appears to have been living a secret life as a biotech ...